Report Detail
Global Flu Vaccine (Influenza Vaccine) Market Insights, Forecast to 2025
- RnM2468345 |
- 20 March, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The classification of Flu Vaccine includes Whole Virus Vaccines, Split Virus Vaccines, Subunit Vaccines and Live Attenuated Virus Vaccines, and the proportion of Whole Virus Vaccines in 2016 is about 43%, and the proportion is in decreasing trend from 2012 to 2016.
Flu Vaccine is widely used for Children (6 months to 3 years) and for Adults and Children over 3 years. The most proportion of Flu Vaccine is For Adults and Children over 3 years, and the proportion in 2016 is about 75%.
The Europe in the EMEA is the largest consumption place, with a consumption market share nearly 80% in 2016. And in the major countries we mentioned in the report, Germany is the largest consumption place with the consumption market share of 12%. Following Russia, France is the second largest consumption region, with the proportion of 11%.
The global Flu Vaccine (Influenza Vaccine) market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Flu Vaccine (Influenza Vaccine) market based on company, product type, end user and key regions.
This report studies the global market size of Flu Vaccine (Influenza Vaccine) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Flu Vaccine (Influenza Vaccine) in these regions.
This research report categorizes the global Flu Vaccine (Influenza Vaccine) market by top players/brands, region, type and end user. This report also studies the global Flu Vaccine (Influenza Vaccine) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
CSL
GSK
Sanofi Pasteur
Mylan
AstraZeneca
Pfizer
Johnson & Johnson
Market size by Product
Whole Virus Vaccines
Split Virus Vaccines
Subunit Vaccines
Live Attenuated Virus Vaccines
Market size by End User
For Children (6 months to 3 years)
For Adults and Children over 3 years
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Flu Vaccine (Influenza Vaccine) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Flu Vaccine (Influenza Vaccine) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Flu Vaccine (Influenza Vaccine) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Flu Vaccine (Influenza Vaccine) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Flu Vaccine (Influenza Vaccine) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Flu Vaccine (Influenza Vaccine) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Flu Vaccine (Influenza Vaccine) Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Flu Vaccine (Influenza Vaccine) Market Size Growth Rate by Product
- 1.4.2 Whole Virus Vaccines
- 1.4.3 Split Virus Vaccines
- 1.4.4 Subunit Vaccines
- 1.4.5 Live Attenuated Virus Vaccines
- 1.5 Market by End User
- 1.5.1 Global Flu Vaccine (Influenza Vaccine) Market Size Growth Rate by End User
- 1.5.2 For Children (6 months to 3 years)
- 1.5.3 For Adults and Children over 3 years
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Flu Vaccine (Influenza Vaccine) Market Size
- 2.1.1 Global Flu Vaccine (Influenza Vaccine) Revenue 2014-2025
- 2.1.2 Global Flu Vaccine (Influenza Vaccine) Sales 2014-2025
- 2.2 Flu Vaccine (Influenza Vaccine) Growth Rate by Regions
- 2.2.1 Global Flu Vaccine (Influenza Vaccine) Sales by Regions
- 2.2.2 Global Flu Vaccine (Influenza Vaccine) Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Flu Vaccine (Influenza Vaccine) Sales by Manufacturers
- 3.1.1 Flu Vaccine (Influenza Vaccine) Sales by Manufacturers
- 3.1.2 Flu Vaccine (Influenza Vaccine) Sales Market Share by Manufacturers
- 3.1.3 Global Flu Vaccine (Influenza Vaccine) Market Concentration Ratio (CR5 and HHI)
- 3.2 Flu Vaccine (Influenza Vaccine) Revenue by Manufacturers
- 3.2.1 Flu Vaccine (Influenza Vaccine) Revenue by Manufacturers (2014-2019)
- 3.2.2 Flu Vaccine (Influenza Vaccine) Revenue Share by Manufacturers (2014-2019)
- 3.3 Flu Vaccine (Influenza Vaccine) Price by Manufacturers
- 3.4 Flu Vaccine (Influenza Vaccine) Manufacturing Base Distribution, Product Types
- 3.4.1 Flu Vaccine (Influenza Vaccine) Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Flu Vaccine (Influenza Vaccine) Product Type
- 3.4.3 Date of International Manufacturers Enter into Flu Vaccine (Influenza Vaccine) Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Flu Vaccine (Influenza Vaccine) Sales by Product
- 4.2 Global Flu Vaccine (Influenza Vaccine) Revenue by Product
- 4.3 Flu Vaccine (Influenza Vaccine) Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Flu Vaccine (Influenza Vaccine) Breakdown Data by End User
6 North America
- 6.1 North America Flu Vaccine (Influenza Vaccine) by Countries
- 6.1.1 North America Flu Vaccine (Influenza Vaccine) Sales by Countries
- 6.1.2 North America Flu Vaccine (Influenza Vaccine) Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Flu Vaccine (Influenza Vaccine) by Product
- 6.3 North America Flu Vaccine (Influenza Vaccine) by End User
7 Europe
- 7.1 Europe Flu Vaccine (Influenza Vaccine) by Countries
- 7.1.1 Europe Flu Vaccine (Influenza Vaccine) Sales by Countries
- 7.1.2 Europe Flu Vaccine (Influenza Vaccine) Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Flu Vaccine (Influenza Vaccine) by Product
- 7.3 Europe Flu Vaccine (Influenza Vaccine) by End User
8 Asia Pacific
- 8.1 Asia Pacific Flu Vaccine (Influenza Vaccine) by Countries
- 8.1.1 Asia Pacific Flu Vaccine (Influenza Vaccine) Sales by Countries
- 8.1.2 Asia Pacific Flu Vaccine (Influenza Vaccine) Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Flu Vaccine (Influenza Vaccine) by Product
- 8.3 Asia Pacific Flu Vaccine (Influenza Vaccine) by End User
9 Central & South America
- 9.1 Central & South America Flu Vaccine (Influenza Vaccine) by Countries
- 9.1.1 Central & South America Flu Vaccine (Influenza Vaccine) Sales by Countries
- 9.1.2 Central & South America Flu Vaccine (Influenza Vaccine) Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Flu Vaccine (Influenza Vaccine) by Product
- 9.3 Central & South America Flu Vaccine (Influenza Vaccine) by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Flu Vaccine (Influenza Vaccine) by Countries
- 10.1.1 Middle East and Africa Flu Vaccine (Influenza Vaccine) Sales by Countries
- 10.1.2 Middle East and Africa Flu Vaccine (Influenza Vaccine) Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Flu Vaccine (Influenza Vaccine) by Product
- 10.3 Middle East and Africa Flu Vaccine (Influenza Vaccine) by End User
11 Company Profiles
- 11.1 CSL
- 11.1.1 CSL Company Details
- 11.1.2 Company Business Overview
- 11.1.3 CSL Flu Vaccine (Influenza Vaccine) Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 CSL Flu Vaccine (Influenza Vaccine) Products Offered
- 11.1.5 CSL Recent Development
- 11.2 GSK
- 11.2.1 GSK Company Details
- 11.2.2 Company Business Overview
- 11.2.3 GSK Flu Vaccine (Influenza Vaccine) Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 GSK Flu Vaccine (Influenza Vaccine) Products Offered
- 11.2.5 GSK Recent Development
- 11.3 Sanofi Pasteur
- 11.3.1 Sanofi Pasteur Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Sanofi Pasteur Flu Vaccine (Influenza Vaccine) Products Offered
- 11.3.5 Sanofi Pasteur Recent Development
- 11.4 Mylan
- 11.4.1 Mylan Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Mylan Flu Vaccine (Influenza Vaccine) Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Mylan Flu Vaccine (Influenza Vaccine) Products Offered
- 11.4.5 Mylan Recent Development
- 11.5 AstraZeneca
- 11.5.1 AstraZeneca Company Details
- 11.5.2 Company Business Overview
- 11.5.3 AstraZeneca Flu Vaccine (Influenza Vaccine) Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 AstraZeneca Flu Vaccine (Influenza Vaccine) Products Offered
- 11.5.5 AstraZeneca Recent Development
- 11.6 Pfizer
- 11.6.1 Pfizer Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Pfizer Flu Vaccine (Influenza Vaccine) Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Pfizer Flu Vaccine (Influenza Vaccine) Products Offered
- 11.6.5 Pfizer Recent Development
- 11.7 Johnson & Johnson
- 11.7.1 Johnson & Johnson Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Johnson & Johnson Flu Vaccine (Influenza Vaccine) Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Johnson & Johnson Flu Vaccine (Influenza Vaccine) Products Offered
- 11.7.5 Johnson & Johnson Recent Development
12 Future Forecast
- 12.1 Flu Vaccine (Influenza Vaccine) Market Forecast by Regions
- 12.1.1 Global Flu Vaccine (Influenza Vaccine) Sales Forecast by Regions 2019-2025
- 12.1.2 Global Flu Vaccine (Influenza Vaccine) Revenue Forecast by Regions 2019-2025
- 12.2 Flu Vaccine (Influenza Vaccine) Market Forecast by Product
- 12.2.1 Global Flu Vaccine (Influenza Vaccine) Sales Forecast by Product 2019-2025
- 12.2.2 Global Flu Vaccine (Influenza Vaccine) Revenue Forecast by Product 2019-2025
- 12.3 Flu Vaccine (Influenza Vaccine) Market Forecast by End User
- 12.4 North America Flu Vaccine (Influenza Vaccine) Forecast
- 12.5 Europe Flu Vaccine (Influenza Vaccine) Forecast
- 12.6 Asia Pacific Flu Vaccine (Influenza Vaccine) Forecast
- 12.7 Central & South America Flu Vaccine (Influenza Vaccine) Forecast
- 12.8 Middle East and Africa Flu Vaccine (Influenza Vaccine) Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Flu Vaccine (Influenza Vaccine) Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Flu Vaccine (Influenza Vaccine) . Industry analysis & Market Report on Flu Vaccine (Influenza Vaccine) is a syndicated market report, published as Global Flu Vaccine (Influenza Vaccine) Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Flu Vaccine (Influenza Vaccine) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
